Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 28;59(3):476.
doi: 10.3390/medicina59030476.

The Relationship between the Presence of an Earlobe Crease and Overactive Bladder: A Cross-Sectional Case-Controlled Study

Affiliations

The Relationship between the Presence of an Earlobe Crease and Overactive Bladder: A Cross-Sectional Case-Controlled Study

Yasufumi Ueda et al. Medicina (Kaunas). .

Abstract

Background and Objectives: To examine the relationship between the presence of earlobe crease (EC) and overactive bladder (OAB). Materials and Methods: The earlobes of the participants were examined macroscopically. ECs were further divided into four groups (grades 0-3) according to severity. Subjective symptoms were assessed using the OAB symptom score (OABSS), and objective findings were assessed using uroflowmetry. The relationship between these findings and the presence or absence and severity of EC was also examined. A score of ≥2 points on OABSS question 3 (urinary urgency), with a total score of ≥3 points, indicated OAB. Results: We analyzed 246 participants, including 120 (48.8%) in the EC group and 126 (51.2%) in the non-EC (N-EC) group. On the OABSS, the EC group scored higher than the N-EC group for all questions and for the total score. The total OABSS of EC grade 3 was the highest of all groups. A total of 115 (95.8%) patients in the EC group (100% in grade 3) and 69 (54.8%) in the N-EC group met the OAB criteria (p < 0.001). The voided volume and maximum flow rate of the EC group were significantly lower than those of the N-EC group (both p < 0.001). The post-void residual urine volume in the EC group was significantly higher than that in the N-EC group (p = 0.029). Multivariate analysis revealed that EC was an independent risk factor for OAB (odds ratio, 8.15; 95% confidence interval, 2.84-24.75; p < 0.001). Conclusions: The presence of an earlobe crease may be a predictive marker for OAB.

Keywords: earlobe crease; lower urinary tract symptom; overactive bladder.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Patient flow diagram.
Figure 2
Figure 2
Representative pictures of grade 3 earlobe crease (arrows).

References

    1. Abramas P., Cardozo L., Fall M., Griffiths D., Rosier P., Ulmsten U., van Kerrebroeck P., Victor A., Wein A., Standardisation The Standardisation of Terminology of Lower Urinary Tract Function: Report from the Standardisation Sub-Committee of the International Continence Society. Neurourol. Urodyn. 2002;21:167–178. doi: 10.1002/nau.10052. - DOI - PubMed
    1. Chen G.D., Lin T.L., Hu S.W., Chen Y.C., Lin L.Y. Prevalence and correlation of urinary incontinence and overactive bladder in Taiwanese women. Neurourol. Urodyn. 2003;22:109–117. doi: 10.1002/nau.10010. - DOI - PubMed
    1. Stewart W.F., Van Rooyen J.B., Cundiff G.W., Abram P., Herzog A.R., Corey R., Hunt T.L., Wein A.J. Prevalence and burden of overactive bladder in the United States. World J. Urol. 2003;20:327–336. doi: 10.1007/s00345-002-0301-4. - DOI - PubMed
    1. Milsom I., Abrams P., Cardozo L., Roberts R.G., Thüroff J., Wein A.J. Erratum: How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001;88:807. - PubMed
    1. Peyronnet B., Mironska E., Chapple C., Cardozo L., Oelke M., Dmochowski R., Amarenco G., Gamé X., Kirby R., Van Der Aa F., et al. A comprehensive review of overactive bladder pathophysiology: On the way to tailored treatment. Eur. Urol. 2019;75:988–1000. doi: 10.1016/j.eururo.2019.02.038. - DOI - PubMed